The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease

S. Häußermann, S. Roeder, D. Türck, G. Wallenstein, K. Sommerer, G. Scheuch (Gauting, Biberach, Germany)

Source: Annual Congress 2003 - Pharmacological treatment strategies in COPD
Session: Pharmacological treatment strategies in COPD
Session type: Thematic Poster Session
Number: 441
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Häußermann, S. Roeder, D. Türck, G. Wallenstein, K. Sommerer, G. Scheuch (Gauting, Biberach, Germany). The lung deposition of tiotropium in COPD patients is comparable to that in healthy subjects and independent of the stage of COPD disease. Eur Respir J 2003; 22: Suppl. 45, 441

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Care-continuity for COPD patients
Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences
Year: 2012


COPD patients
Source: Eur Respir Monogr 2021; 90: 154-164
Year: 2021


Lung deposition of carmoterol in healthy subjects, patients with asthma and patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 211s
Year: 2006

Mucocilary clearance of COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 35s
Year: 2006

The positive effect of cilomilast on lung function in patients with chronic obstructive pulmonary disease (COPD) is independent of patient smoking status
Source: Eur Respir J 2002; 20: Suppl. 38, 620s
Year: 2002

Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007



Patients at risk for COPD compared to patients diagnosed with COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009


COPD, asthma, and lung cancer patients
Source: International Congress 2016 – ME13 Smoking cessation in difficult population groups
Year: 2016



Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials
Source: Eur Respir J 2006; 28: Suppl. 50, 175s
Year: 2006

A comparison of three different methods for analysing airway resistance in healthy subjects, asthma and chronic obstructive pulmonary disease patients
Source: Eur Respir J 2007; 30: Suppl. 51, 177s
Year: 2007

Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


Catabolic/anabolic balance in patients with COPD exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004

Systemic and airways inflammation in healthy subjects and COPD patients of different ages
Source: Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation
Year: 2007


SPECT measurement of perfused lung volume in patients with COPD, patients with restrictive lung disease and healthy volunteers
Source: Annual Congress 2010 - Infection, inflammation and destruction
Year: 2010


Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers
Source: Eur Respir J 2004; 24: Suppl. 48, 39s
Year: 2004

The lower airways microbiome in patients with IPF and COPD
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019

Lung volume response to bronchodilators is dependent on the stage of the disease in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2006 - COPD therapy
Year: 2006


A clinical study of lung cancer cases with underlying COPD in relation to the COPD phenotype
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010


Vip in the serum of asthmatic patients and in COPD patients in stable state and during exacerbation
Source: Eur Respir J 2007; 30: Suppl. 51, 403s
Year: 2007

The course of disease of patients who died from asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 217s
Year: 2003